Equels Thomas K, CEO and President of AIM ImmunoTech Inc. ($AIM), made four open market purchases of company shares over the past year, totaling roughly $54,300. His most recent buy occurred on June 13, 2025. These purchases rank 2,890th among 4,983 insiders in our database, where the average buy amounts to $1.46 million across 3.29 transactions. Equels Thomas K reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | C | Common stock | 25000 | $0.00 | 63,922.0000 | 2,853,114 | 64.23% | 0.88% |
| March 12, 2026 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | C | Series G Convertible Preferred Stock | 25 | $0.00 | 0.0000 | 2,853,114 | 100.00% | 0.00% |
| March 6, 2026 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | J | Class G Warrants | 50000 | $0.00 | 50,000.0000 | 2,853,114 | 9999.99% | 1.75% |
| March 6, 2026 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | J | Series G Convertible Preferred Stock | 25 | $25000.00 | 25.0000 | 2,853,114 | 9999.99% | 0.00% |
| June 13, 2025 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | P | Common Stock | 107 | $7.70 | 38,885.0000 | 72,290,030 | 0.28% | 0.00% |
| June 12, 2025 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | P | Common Stock | 103 | $8.70 | 38,675.0000 | 72,290,030 | 0.27% | 0.00% |
| April 11, 2025 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | P | Common Stock | 1968504 | $0.03 | 3,867,533.0000 | 72,290,030 | 103.66% | 2.72% |
| April 4, 2025 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | P | Common Stock | 41000 | $0.06 | 1,899,029.0000 | 72,290,030 | 2.21% | 0.06% |
| March 5, 2025 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | P | Common Stock | 50000 | $0.13 | 1,858,029.0000 | 0 | 2.77% | 0.00% |
| March 4, 2025 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | P | Common Stock | 44000 | $0.12 | 1,808,029.0000 | 0 | 2.49% | 0.00% |
| March 4, 2025 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | P | Common Stock | 83334 | $0.12 | 1,764,029.0000 | 0 | 4.96% | 0.00% |
| Nov. 21, 2024 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | P | Common Stock | 20000 | $0.21 | 1,657,968.0000 | 0 | 1.22% | 0.00% |
| Dec. 18, 2024 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | P | Common Stock | 22727 | $0.21 | 1,680,695.0000 | 0 | 1.37% | 0.00% |
| Nov. 20, 2024 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | P | Common Stock | 85000 | $0.20 | 1,637,968.0000 | 0 | 5.47% | 0.00% |
| Nov. 20, 2024 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | P | Common Stock | 60110 | $0.18 | 1,552,968.0000 | 0 | 4.03% | 0.00% |
| Sept. 16, 2024 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | P | Common Stock | 5000 | $0.30 | 1,493,042.0000 | 0 | 0.34% | 0.00% |
| Sept. 13, 2024 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | P | Common Stock | 20000 | $0.31 | 1,488,042.0000 | 0 | 1.36% | 0.00% |
| Sept. 11, 2024 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | A | Common Stock | 312500 | $0.32 | 1,468,042.0000 | 0 | 27.04% | 0.00% |
| Aug. 12, 2024 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | A | Common Stock | 377358 | $0.27 | 1,155,542.0000 | 0 | 48.49% | 0.00% |
| May 6, 2024 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | P | Common Stock | 61729 | $0.41 | 778,184.0000 | 0 | 8.62% | 0.00% |
| Nov. 30, 2023 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | A | Options | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| March 15, 2024 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | P | Common Stock | 75758 | $0.33 | 716,455.0000 | 0 | 11.82% | 0.00% |
| Nov. 27, 2023 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | P | Common Stock | 33861 | $0.44 | 640,697.0000 | 0 | 5.58% | 0.00% |
| Sept. 29, 2023 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | P | Common Stock | 22676 | $0.44 | 606,836.0000 | 0 | 3.88% | 0.00% |
| Aug. 25, 2023 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | P | Common Stock | 8222 | $0.67 | 584,160.0000 | 0 | 1.43% | 0.00% |
| Aug. 24, 2023 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | P | Common Stock | 14993 | $0.67 | 575,938.0000 | 0 | 2.67% | 0.00% |
| July 17, 2023 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | P | Common Stock | 16950 | $0.59 | 560,945.0000 | 0 | 3.12% | 0.00% |
| Jan. 3, 2023 | AIM ImmunoTech Inc. | $AIM | Equels Thomas K | CEO & President | P | Common Stock | 161291 | $0.31 | 543,995.0000 | 0 | 42.15% | 0.00% |